Display options
Share it on

Front Neurosci. 2011 Feb 10;5:15. doi: 10.3389/fnins.2011.00015. eCollection 2011.

Voluntary Ethanol Consumption Induced by Social Isolation Reverses the Increase of α(4)/δ GABA(A) Receptor Gene Expression and Function in the Hippocampus of C57BL/6J Mice.

Frontiers in neuroscience

Enrico Sanna, Giuseppe Talani, Nicola Obili, Maria Paola Mascia, Maria Cristina Mostallino, Pietro Paolo Secci, Maria Giuseppina Pisu, Francesca Biggio, Cinzia Utzeri, Pierluigi Olla, Giovanni Biggio, Paolo Follesa

Affiliations

  1. Section of Neuroscience, Department of Experimental Biology, Center of Excellence for the Neurobiology of Dependence, University of Cagliari Monserrato, Cagliari, Italy.

PMID: 21347217 PMCID: PMC3039156 DOI: 10.3389/fnins.2011.00015

Abstract

Post-weaning social isolation (SI) is a model of prolonged mild stress characterized by behavioral and neurochemical alterations. We used SI in C57BL/6J mice to investigate the effects of ethanol (EtOH) in the free-choice drinking paradigm on gene expression and function of γ-aminobutyric acid type A receptors (GABA(A)Rs) and the role of neuroactive steroids in the actions of EtOH in the hippocampus. SI stress induced a marked reduction in hippocampal 3α-hydroxy-5α-pregnan-20-one (3α,5α-TH PROG) and was associated with molecular and functional changes of the GABA(A)R. The gene expression of the α(4) and δ subunits was increased in the hippocampus of SI C57BL/6J mice; the expression of the γ(2) subunit was decreased whereas that of the α(1) did not change. Patch-clamp recordings in dentate gyrus (DG) granule cells obtained from SI C57BL/6J mice revealed a greater enhancement of tonic currents induced by α-(4,5,6,7-tetrahydroisoxazolo[5,4-c] pyridin-3-ol (THIP) compared to that in control C57BL/6J mice. These neurochemical, molecular and functional changes observed in SI C57BL/6J mice were associated with an increased EtOH intake and EtOH preference. Nevertheless, the increase in EtOH consumption did not restore the reduction in hippocampal 3α,5α-TH PROG induced by SI. EtOH self-administration blocked the changes in gene expression of the α(4) subunit but not those of the δ and γ(2) subunits induced by SI. In addition, EtOH self-administration did not block the SI-induced changes in GABA(A)R-mediated tonic inhibition in hippocampal granule cells but increased the frequency of basal GABAergic sIPSCs in DG granule cells. We conclude that self-administration of EtOH selectively abolishes the increase of α(4) subunit but not other neurochemical, molecular, and functional modifications induced by SI prolonged mild stress.

Keywords: GABAA receptor; allopregnanolone; ethanol; gene expression; hippocampus; patch-clamp; social isolation; stress

References

  1. Eur J Neurosci. 2006 Nov;24(10):2894-902 - PubMed
  2. J Neurochem. 2003 Apr;85(1):257-63 - PubMed
  3. Prog Neurobiol. 1998 Aug;55(5):509-35 - PubMed
  4. Alcohol Clin Exp Res. 1999 Dec;23(12):1933-40 - PubMed
  5. Cereb Cortex. 2006 Aug;16(8):1134-41 - PubMed
  6. Psychopharmacology (Berl). 1998 Oct;139(3):210-6 - PubMed
  7. Eur J Pharmacol. 1999 Nov 19;384(2-3):R1-2 - PubMed
  8. Alcohol Clin Exp Res. 2006 Dec;30(12):2008-16 - PubMed
  9. J Comp Physiol Psychol. 1964 Feb;57:85-8 - PubMed
  10. Br J Pharmacol. 2002 Aug;136(7):965-74 - PubMed
  11. J Neurosci. 2004 Nov 24;24(47):10679-86 - PubMed
  12. J Neurosci. 2009 Feb 11;29(6):1755-65 - PubMed
  13. Alcohol. 2008 May;42(3):149-60 - PubMed
  14. J Neurosci. 1998 Jul 15;18(14):5275-84 - PubMed
  15. Brain Res Brain Res Rev. 2001 Nov;37(1-3):98-109 - PubMed
  16. Trends Neurosci. 2004 May;27(5):262-9 - PubMed
  17. Alcohol. 2011 Jun;45(4):355-64 - PubMed
  18. Steroids. 1990 Jul;55(7):290-6 - PubMed
  19. J Neurosci. 2006 Feb 8;26(6):1749-58 - PubMed
  20. Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15218-23 - PubMed
  21. Exp Neurol. 2003 Oct;183(2):600-9 - PubMed
  22. Nature. 1998 Apr 30;392(6679):926-30 - PubMed
  23. Alcohol Clin Exp Res. 1999 Oct;23(10):1563-70 - PubMed
  24. Psychopharmacology (Berl). 1993;112(4):503-10 - PubMed
  25. Mol Pharmacol. 2003 Apr;63(4):896-907 - PubMed
  26. Psychopharmacology (Berl). 1990;101(2):233-9 - PubMed
  27. J Neurosci. 2000 Mar 1;20(5):1982-9 - PubMed
  28. J Neurosci. 2003 Dec 17;23(37):11711-24 - PubMed
  29. Hippocampus. 2004;14(4):482-98 - PubMed
  30. J Neurophysiol. 2002 May;87(5):2624-8 - PubMed
  31. J Neurosci. 2004 Sep 22;24(38):8379-82 - PubMed
  32. Mol Pharmacol. 2003 Jan;63(1):53-64 - PubMed
  33. J Neurochem. 1998 Mar;70(3):1160-6 - PubMed
  34. Nat Neurosci. 2002 Aug;5(8):721-2 - PubMed
  35. Brain Res. 2003 Nov 21;991(1-2):271-3 - PubMed
  36. Endocrinology. 1992 Aug;131(2):585-94 - PubMed
  37. Biol Psychiatry. 1974 Dec;9(3):329-34 - PubMed
  38. Brain Res Mol Brain Res. 1996 Sep 5;41(1-2):163-8 - PubMed
  39. J Neurochem. 2006 Jul;98(1):122-33 - PubMed
  40. J Pharmacol Exp Ther. 2006 Mar;316(3):1360-8 - PubMed
  41. Neurochem Int. 2000 Nov-Dec;37(5-6):453-61 - PubMed
  42. Neurosci Biobehav Rev. 2008 Aug;32(6):1087-102 - PubMed
  43. Eur Neuropsychopharmacol. 2011 May;21(5):414-25 - PubMed
  44. Neuropharmacology. 1999 Jul;38(7):955-63 - PubMed
  45. Eur J Neurosci. 1998 Sep;10(9):2905-12 - PubMed
  46. Genes Brain Behav. 2005 Jun;4(4):240-52 - PubMed
  47. Neuroscience. 2003;121(3):787-99 - PubMed
  48. J Neurochem. 2005 Aug;94(3):659-71 - PubMed
  49. Neuron. 2008 Jul 31;59(2):207-13 - PubMed
  50. Alcohol Clin Exp Res. 2001 May;25(5 Suppl ISBRA):76S-81S - PubMed
  51. Alcohol Clin Exp Res. 2005 Apr;29(4):591-601 - PubMed
  52. Alcohol. 1990 Jul-Aug;7(4):321-6 - PubMed
  53. Psychopharmacology (Berl). 2001 Dec;158(4):366-73 - PubMed
  54. Alcohol Clin Exp Res. 1986 Aug;10(4):436-42 - PubMed
  55. J Neurosci. 2004 Jul 21;24(29):6521-30 - PubMed
  56. Neuropharmacology. 2010 Jun;58(7):1179-86 - PubMed
  57. Psychopharmacologia. 1976 Mar 16;46(2):185-9 - PubMed
  58. World J Biol Psychiatry. 2002 Apr;3(2):87-95 - PubMed
  59. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2053-8 - PubMed
  60. Psychopharmacology (Berl). 2009 Sep;205(4):529-64 - PubMed
  61. Psychopharmacology (Berl). 2008 May;197(4):613-28 - PubMed
  62. Brain Res Brain Res Rev. 1999 Apr;29(2-3):196-217 - PubMed
  63. Nat Neurosci. 2005 Jun;8(6):797-804 - PubMed
  64. Psychopharmacology (Berl). 2008 Dec;201(3):459-68 - PubMed
  65. J Pharmacol Exp Ther. 2006 Oct;319(1):431-8 - PubMed
  66. Trends Neurosci. 1994 Dec;17(12):517-25 - PubMed
  67. Psychopharmacology (Berl). 1998 Sep;139(1-2):2-19 - PubMed
  68. J Neurochem. 2000 Aug;75(2):732-40 - PubMed
  69. J Neurosci. 2007 Nov 7;27(45):12367-77 - PubMed
  70. Neurochem Res. 2005 Dec;30(12):1579-88 - PubMed
  71. J Neurophysiol. 2008 Dec;100(6):3417-28 - PubMed
  72. Proc Natl Acad Sci U S A. 2003 May 27;100(11):6813-8 - PubMed
  73. Int J Neuropsychopharmacol. 2007 Oct;10(5):595-607 - PubMed
  74. Physiol Behav. 2009 Jun 22;97(3-4):385-93 - PubMed
  75. J Neurosci. 2008 Feb 6;28(6):1421-6 - PubMed

Publication Types

Grant support